VICTORIA SISSOM: Open Payments
NPI 1922596261 · ALCOA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$279 in 16 payments from 7 companies in 2025. Trend: 2023 $99 · 2024 $264 · 2025 $279
Food & beverage: $279
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Novo Nordisk Inc | 2 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: AIRSUPRA, Ozempic, GVOKE HYPOPEN, TRELEGY ELLIPTA, MOUNJARO, FARXIGA, PREVNAR 20, JARDIANCE.
Industry payments across TN — which companies pay providers there.
